BRCA1 and cancer: By entering the mainstream of clinical practice, genetic testing for BRCA1/2 has allowed individuals with cancer or an increased risk of cancer to choose personalized prevention, surveillance or treatment options which are appropriate for their level of risk and which are intended to reduce morbidity and mortality.